Daily myo-inositol supplementation during pregnancy might not reduce the risk for major complications for individuals with polycystic ovary syndrome (PCOS), according to new research. The findings ...
A recent study in JAMA assessed the efficacy of myo-inositol supplementation during pregnancy in terms of lowering the risk of a composite outcome of preeclampsia, gestational diabetes, and preterm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback